Provided by Tiger Trade Technology Pte. Ltd.

Invesco RAFI US 1000 ETF

55.48
-0.2600-0.47%
Post-market: 55.480.00000.00%19:30 EDT
Volume:284.63K
Turnover:15.80M
Market Cap:9.94B
PE:34.67
High:55.71
Open:55.58
Low:55.43
Close:55.74
52wk High:56.66
52wk Low:44.11
Shares:179.09M
Float Shares:179.09M
Volume Ratio:1.03
T/O Rate:0.16%
Dividend:0.74
Dividend Rate:1.34%
EPS(TTM):1.60
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

PRF Technologies Unveils Stronger Preclinical Data for PRF-110 vs. ZYNRELEF

TIPRANKS
·
Jun 26

PRF Technologies Says PRF-110 Showed Comparable Efficacy to Zynrelef in Preclinical Study

MT Newswires Live
·
Jun 25

PRF Technologies announces expanded results from PRF-110 study

TIPRANKS
·
Jun 25

PRF Technologies Reports Expanded Preclinical Results for PRF-110 in Head-to-Head Comparison with Approved Benchmark

GlobeNewswire
·
Jun 25

PRF Technologies files to sell 7.5M ordinary shares for holders

TIPRANKS
·
Jun 23

PRF Technologies Secures New $15 Million Standby Equity Facility with Yorkville

TIPRANKS
·
Jun 19

Why Is Penny Stock PRF Technologies (PRFX) Up Today?

TIPRANKS
·
May 29

PRF Technologies Speeds DeepSolar Predict Toward Commercial Launch for AI-Driven Renewable Revenue Optimization

TIPRANKS
·
May 28

PRF Technologies Advances DeepSolar Predict™ Toward Commercial Launch as AI Platform Targets Revenue Optimization Across Renewable Energy Markets

GlobeNewswire
·
May 28

PRF Technologies announces results from study comparing PRF-110 to Zynrelef

TIPRANKS
·
May 26

PRF Technologies Announces PRF-110 Demonstrated Sustained 72-Hour Analgesic Activity Comparable to Approved, Commercially Available Benchmark in Head-to-Head Preclinical Study

GlobeNewswire
·
May 26

PRF Technologies registers to sell 3M ordinary shares for holders

TIPRANKS
·
May 14

Press Release: First Horizon Declares Cash Dividends on Common and Preferred Stock

Dow Jones
·
Apr 29

PRF Technologies announces FDA clearance of OcuRing-K NDA

TIPRANKS
·
Apr 28

PRF Technologies Announces FDA Clearance of IND Application for OcuRing™-K Phase II Clinical Trial

GlobeNewswire
·
Apr 28

What's Going On With Pharma Company PRF Technologies On Tuesday?

Benzinga Earnings
·
Apr 07

PRF Technologies Posts 2025 Results as LayerBio and DeepSolar Deals Drive Dual-Platform Pivot

TIPRANKS
·
Mar 27

PRF Technologies In FY25 Had ~$4.1M In Cash, Cash Equivalents, Short-Term Deposits And Restricted Cash And Positive Working Capital Of ~$1.9M

Benzinga Earnings
·
Mar 27

PRF Technologies Provides Year-End 2025 Business Update Highlighting Strategic Progress Across Healthcare and AI-Driven Solar Platforms

GlobeNewswire
·
Mar 27